Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Calmels

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host diseaseRaynier Devillier, Sabine Fürst, Jean El-Cheikh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor ComparisonRaynier Devillier, Faezeh Legrand, Jérôme Rey, et al.
American Journal of Hematology|October 11, 2013
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donorRaynier Devillier, Sabine Fürst, Roberto Crocchiolo, et al.
Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.
Frontiers in Oncology|April 27, 2026
Clinical implementation of a one-step no-wash flow cytometry method allows for real-time monitoring of patients treated with autologous CAR-T cellsNassim Salem, Clémence Demerlé, Bechara Mfarrej, et al.
Bone Marrow Transplantation|June 27, 2026
Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patientsGuillaume Berton, Sabine Fürst, Benjamin Bouchacourt, et al.
Bone Marrow Transplantation|November 4, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndromeSamia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.
Plos Biology|November 20, 2004
Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cellsPeiman Hematti, Bum-Kee Hong, Cole Ferguson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemiaHans-Peter Kiem, Stephanie Sellers, Bobbie Thomasson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 PatientsThomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 10, 2013
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host diseaseRaynier Devillier, Sabine Fürst, Jean El-Cheikh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 16, 2018
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor ComparisonRaynier Devillier, Faezeh Legrand, Jérôme Rey, et al.
American Journal of Hematology|October 11, 2013
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donorRaynier Devillier, Sabine Fürst, Roberto Crocchiolo, et al.
Bone Marrow Transplantation|March 21, 2019
Peripheral blood stem cell for haploidentical transplantation with post-transplant high dose cyclophosphamide: detailed analysis of 181 consecutive patientsAngela Granata, Sabine Fürst, Stefania Bramanti, et al.
Frontiers in Oncology|April 27, 2026
Clinical implementation of a one-step no-wash flow cytometry method allows for real-time monitoring of patients treated with autologous CAR-T cellsNassim Salem, Clémence Demerlé, Bechara Mfarrej, et al.
Bone Marrow Transplantation|June 27, 2026
Fludarabine, cyclophosphamide and 2 Gy TBI with PT-Cy as a single platform for haplo and unrelated donor allo-SCT in older AML or MDS patientsGuillaume Berton, Sabine Fürst, Benjamin Bouchacourt, et al.
Bone Marrow Transplantation|November 4, 2023
Peripheral blood haploidentical hematopoietic cell transplantation for patients aged 70 years and over with acute myeloid leukemia or high-risk myelodysplastic syndromeSamia Harbi, Louison Brac de la Perriere, Benjamin Bouchacourt, et al.
Plos Biology|November 20, 2004
Distinct genomic integration of MLV and SIV vectors in primate hematopoietic stem and progenitor cellsPeiman Hematti, Bum-Kee Hong, Cole Ferguson, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 10, 2004
Long-term clinical and molecular follow-up of large animals receiving retrovirally transduced stem and progenitor cells: no progression to clonal hematopoiesis or leukemiaHans-Peter Kiem, Stephanie Sellers, Bobbie Thomasson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 26, 2019
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 PatientsThomas Pagliardini, Lucas Castagna, Samia Harbi, et al.
Pageof 7